MENU
DBVT
Stock ticker: NASDAQ
PRICE
CHANGE
CAPITALIZATION
DBV Technologies S.A (DBVT) Earnings Date & Reports
DBV Technologies SA is a clinical-stage specialty biopharmaceutical company focused on changing the field of immunotherapy by developing a novel technology platform called Viaskin... Show more
Industry: #Biotechnology
A.I. Advisor
published Earnings
DBVT is expected to report earnings to rise 160.87% to -60 cents per share on October 27
Q3'26
Est.
$-0.60
Q4'24
Est.
$-0.23
Q1'24
Missed
by $0.05
Q4'23
Beat
by $0.02
Q3'23
Beat
by $0.07
The last earnings report on April 11 showed earnings per share of -23 cents, missing the estimate of -22 cents. With 47.10K shares outstanding, the current market capitalization sits at 608.37M.
View a ticker or compare two or three
VS
VS
Interact to see
Advertisement
Advertisement
A.I.Advisor
published price charts
Interesting Articles
A.I. Advisor
published General Information
General Information
a developer of non invasive epicutaneous diagnostics systems and immunotherapy for allergy diagnostics
Industry Biotechnology
Industry
Biotechnology
Address
107 Avenue de la Republique
Phone
+33 155427878
Employees
126
Web
https://www.dbv-technologies.com